Hepatic β-arrestin 2 is essential for maintaining euglycemia.
Saved in:
| Title: | Hepatic β-arrestin 2 is essential for maintaining euglycemia. |
|---|---|
| Authors: | Zhu L; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Rossi M; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Cui Y; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Lee RJ; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Sakamoto W; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA., Perry NA; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA., Urs NM; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA., Caron MG; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA., Gurevich VV; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA., Godlewski G; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Kunos G; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA., Chen M; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Chen W; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Wess J; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2017 Aug 01; Vol. 127 (8), pp. 2941-2945. Date of Electronic Publication: 2017 Jun 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 28650340 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hepatic β-arrestin 2 is essential for maintaining euglycemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhu+L%22">Zhu L</searchLink>; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Rossi+M%22">Rossi M</searchLink>; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Cui+Y%22">Cui Y</searchLink>; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Lee+RJ%22">Lee RJ</searchLink>; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Sakamoto+W%22">Sakamoto W</searchLink>; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Perry+NA%22">Perry NA</searchLink>; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Urs+NM%22">Urs NM</searchLink>; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Caron+MG%22">Caron MG</searchLink>; Department of Cell Biology, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Gurevich+VV%22">Gurevich VV</searchLink>; Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, USA.<br /><searchLink fieldCode="AU" term="%22Godlewski+G%22">Godlewski G</searchLink>; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Kunos+G%22">Kunos G</searchLink>; Laboratory of Physiologic Studies, National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Chen+M%22">Chen M</searchLink>; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Chen+W%22">Chen W</searchLink>; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Wess+J%22">Wess J</searchLink>; Molecular Signaling Section, Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227802877%22">The Journal of clinical investigation</searchLink> [J Clin Invest] 2017 Aug 01; Vol. 127 (8), pp. 2941-2945. <i>Date of Electronic Publication: </i>2017 Jun 26. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+for+Clinical+Investigation%22">American Society for Clinical Investigation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7802877 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1558-8238 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200219738%22">00219738 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Invest <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=28650340 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1172/JCI92913 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2941 Titles: – TitleFull: Hepatic β-arrestin 2 is essential for maintaining euglycemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhu L – PersonEntity: Name: NameFull: Rossi M – PersonEntity: Name: NameFull: Cui Y – PersonEntity: Name: NameFull: Lee RJ – PersonEntity: Name: NameFull: Sakamoto W – PersonEntity: Name: NameFull: Perry NA – PersonEntity: Name: NameFull: Urs NM – PersonEntity: Name: NameFull: Caron MG – PersonEntity: Name: NameFull: Gurevich VV – PersonEntity: Name: NameFull: Godlewski G – PersonEntity: Name: NameFull: Kunos G – PersonEntity: Name: NameFull: Chen M – PersonEntity: Name: NameFull: Chen W – PersonEntity: Name: NameFull: Wess J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2017 Aug 01 Type: published Y: 2017 Identifiers: – Type: issn-electronic Value: 1558-8238 Numbering: – Type: volume Value: 127 – Type: issue Value: 8 Titles: – TitleFull: The Journal of clinical investigation Type: main |
| ResultId | 1 |
